According to Santé Publique France, in 2022, cancer was the leading cause of death in France, accounting for 25.5% of deaths, despite significant improvements in therapeutic management over recent decades.
In addition to antitumor therapy, care includes a nutritional and physical activity approach aimed at maintaining patients’ quality of life and well-being, as well as preventing cancer-related muscle mass loss.
The devices developed by Aminogram provide a fast, simple, non-invasive, and accurate method for assessing health risks and measuring the impact of interventions based on body composition data. In less than 10 seconds, the analysis allows to:
With the devices developed by Aminogram, provide personalized and precise monitoring for improved care of patients with cancer.
Fill out the form below and we’ll get back to you as soon as possible.
Remplissez le formulaire ci-dessous et nous vous contacterons dans les plus brefs délais.